LMO7-mediated POLR2A degradation promotes cellular senescence through the MDM4/p53/p21 axis

Wait 5 sec.

LMO7-mediated POLR2A degradation promotes cellular senescence through the MDM4/p53/p21 axisDownload PDF Download PDF ArticleOpen accessPublished: 28 March 2026Chutong Lai1,2,Wen Fu1,2,Jiaxin Liu1,2,Shuai Hou  ORCID: orcid.org/0000-0001-5274-52641,2,Jinsong Yan  ORCID: orcid.org/0000-0003-4109-26023 &…Haixin Lei  ORCID: orcid.org/0000-0003-2445-81311,2,4 Cell Death & Disease , Article number:  (2026) Cite this article We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.SubjectsSenescenceTranscriptionUbiquitylationAbstractAs the largest subunit of RNA polymerase II, POLR2A plays an irreplaceable role in gene expression, with the regulation of its own expression and physiological function having attracted widespread attention. Here we report POLR2A as a critical guardian against cellular senescence. A significant decline in POLR2A expression was observed in senescent cells and certain tissues of aging mice. Whereas its depletion dramatically induced cellular senescence, conversely, activating endogenous POLR2A expression in senescent cells using CRISPRa technology alleviated the senescent phenotype. We further demonstrated that POLR2A-induced senescence is p53-dependent, as evidenced by the activation of the p53/p21 pathway upon POLR2A knockdown and the rescue of the senescence phenotype following co-depletion of POLR2A and p53. Bioinformatic analysis on RNA-seq data from POLR2A depletion and replicative senescent cells led to the identification of MDM4 as the key mediator of p53 upregulation following POLR2A knockdown. Most intriguingly, immunoprecipitation assay further revealed that the E3 ligase LMO7 was recruited to POLR2A to promote the ubiquitination and proteasomal degradation of POLR2A under cellular senescence. Depletion of LMO7 abolished the ubiquitination and reduction of POLR2A in H₂O₂-induced senescent cells. Taken together, we concluded that the LMO7-induced POLR2A degradation drived cellular senescence through the MDM4/p53/p21 axis.Data availabilityThe data that support this study are available from the corresponding author upon request. The raw sequence data reported in this paper have been deposited in the Genome Sequence Archive in National Genomics Data Center[39], China National Center for Bioinformation / Beijing Institute of Genomics, Chinese Academy of Sciences (GSA-Human: HRA013617) that are publicly accessible at https://ngdc.cncb.ac.cn/gsa-human/browse/HRA013617.ReferencesVervoort SJ, Devlin JR, Kwiatkowski N, Teng M, Gray NS, Johnstone RW. Targeting transcription cycles in cancer. Nat Rev Cancer. 2022;22:5–24.Google Scholar Debes C, Papadakis A, Gronke S, Karalay O, Tain LS, Mizi A, et al. Ageing-associated changes in transcriptional elongation influence longevity. Nature. 2023;616:814–21.Google Scholar Papantonis A, Antebi A, Partridge L, Beyer A. Age-associated changes in transcriptional elongation and their effects on homeostasis. Trends Cell Biol. 2025;35:645–50.Google Scholar Noe Gonzalez M, Blears D, Svejstrup JQ. Causes and consequences of RNA polymerase II stalling during transcript elongation. Nat Rev Mol Cell Biol. 2021;22:3–21.Google Scholar Wilson MD, Harreman M, Svejstrup JQ. Ubiquitylation and degradation of elongating RNA polymerase II: the last resort. Biochim Biophys Acta. 2013;1829:151–7.Google Scholar Reese JC. New roles for elongation factors in RNA polymerase II ubiquitylation and degradation. Biochim Biophys Acta Gene Regul Mech. 2023;1866:194956.Google Scholar Anindya R, Aygun O, Svejstrup JQ. Damage-induced ubiquitylation of human RNA polymerase II by the ubiquitin ligase Nedd4, but not Cockayne syndrome proteins or BRCA1. Mol Cell. 2007;28:386–97.Google Scholar Caron P, Pankotai T, Wiegant WW, Tollenaere MAX, Furst A, Bonhomme C, et al. WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks. Genes Dev. 2019;33:684–704.Google Scholar Nakazawa Y, Hara Y, Oka Y, Komine O, van den Heuvel D, Guo C, et al. Ubiquitination of DNA damage-stalled RNAPII promotes transcription-coupled repair. Cell. 2020;180:1228–44.e24.Google Scholar Lao L, Bourdeau I, Gagliardi L, He X, Shi W, Hao B, et al. ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. Nucleic Acids Res. 2022;50:6343–67.Google Scholar Clark VE, Harmanci AS, Bai H, Youngblood MW, Lee TI, Baranoski JF, et al. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet. 2016;48:1253–9.Google Scholar Zhang D, Wang X, Lu S, Gao Y, Zhu G, Li G, et al. USP10 inhibits ferroptosis via deubiquinating POLR2A in head and neck squamous cell carcinoma. Adv Sci. 2025:12:e12271.Gonzalo-Hansen C, Steurer B, Janssens RC, Zhou D, van Sluis M, Lans H, et al. Differential processing of RNA polymerase II at DNA damage correlates with transcription-coupled repair syndrome severity. Nucleic Acids Res. 2024;52:9596–612.Google Scholar Ding Y, Zuo Y, Zhang B, Fan Y, Xu G, Cheng Z, et al. Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures. Cell. 2025;188:5763–84.Google Scholar Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243–78.Google Scholar Kyng KJ, May A, Kolvraa S, Bohr VA. Gene expression profiling in Werner syndrome closely resembles that of normal aging. Proc Natl Acad Sci USA. 2003;100:12259–64.Google Scholar Hou S, Qu D, Li Y, Zhu B, Liang D, Wei X, et al. XAB2 depletion induces intron retention in POLR2A to impair global transcription and promote cellular senescence. Nucleic Acids Res. 2019;47:8239–54.Google Scholar Aging Biomarker C, Bao H, Cao J, Chen M, Chen M, Chen W, et al. Biomarkers of aging. Sci China Life Sci. 2023;66:893–1066.Google Scholar Wade M, Wang YV, Wahl GM. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 2010;20:299–309.Google Scholar Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell. 2024;42:946–67.Google Scholar Wu H, Pomeroy SL, Ferreira M, Teider N, Mariani J, Nakayama KI, et al. UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53. Nat Med. 2011;17:347–55.Google Scholar Jain AK, Barton MC. Regulation of p53: TRIM24 enters the RING. Cell Cycle. 2009;8:3668–74.Google Scholar Doyle JM, Gao J, Wang J, Yang M, Potts PR. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell. 2010;39:963–74.Google Scholar Rong X, Rao J, Li D, Jing Q, Lu Y, Ji Y. TRIM69 inhibits cataractogenesis by negatively regulating p53. Redox Biol. 2019;22:101157.Google Scholar Zhang L, Huang NJ, Chen C, Tang W, Kornbluth S. Ubiquitylation of p53 by the APC/C inhibitor Trim39. Proc Natl Acad Sci USA. 2012;109:20931–6.Google Scholar Tripathi V, Kaur E, Kharat SS, Hussain M, Damodaran AP, Kulshrestha S, et al. Abrogation of FBW7alpha-dependent p53 degradation enhances p53’s function as a tumor suppressor. J Biol Chem. 2019;294:13224–32.Google Scholar Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, et al. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell. 2003;112:779–91.Google Scholar Lee JT, Gu W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 2010;17:86–92.Google Scholar Du D, Qi LS CRISPR technology for genome activation and repression in mammalian Cells. Cold Spring Harb Protoc. 2016;2016:pdb prot090175.Xu P, Liu Y, Liu C, Guey B, Li L, Melenec P, et al. The CRL5-SPSB3 ubiquitin ligase targets nuclear cGAS for degradation. Nature. 2024;627:873–9.Google Scholar Wu T, Chen X, Xu K, Dai C, Li X, Zhang YW, et al. LIM domain only 7 negatively controls nonalcoholic steatohepatitis in the setting of hyperlipidemia. Hepatology. 2024;79:149–66.Google Scholar Wang X, Wang J, Jiang X. MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination. J Biol Chem. 2011;286:23725–34.Google Scholar Raj N, Attardi LD. The transactivation domains of the p53 protein. Cold Spring Harb Perspect Med. 2017;7:a026047.Google Scholar Mathieu D, Mathieu D, Marc-Alexandre O, Alicia P-V, Francis R, Benoit C. A defective splicing machinery promotes senescence through MDM4 alternative splicing. Aging Cell. 2024;23:e14301.Google Scholar Te Velthuis AJ, Isogai T, Gerrits L, Bagowski CP. Insights into the molecular evolution of the PDZ/LIM family and identification of a novel conserved protein motif. PLoS ONE. 2007;2:e189.Google Scholar Ooshio T, Irie K, Morimoto K, Fukuhara A, Imai T, Takai Y. Involvement of LMO7 in the association of two cell-cell adhesion molecules, nectin and E-cadherin, through afadin and alpha-actinin in epithelial cells. J Biol Chem. 2004;279:31365–73.Google Scholar Dai S, Peng Y, Wang G, Chen C, Chen Q, Yin L, et al. LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancreatic ductal adenocarcinoma. Cell Death Differ. 2025;32:271–90.Google Scholar Bendixen L, Jensen TI, Bak RO. CRISPR-Cas-mediated transcriptional modulation: the therapeutic promises of CRISPRa and CRISPRi. Mol Ther. 2023;31:1920–37.Google Scholar Zhang S, Chen X, Jin E, Wang A, Chen T, Zhang X, et al. The GSA family in 2025: a broadened sharing platform for multi-omics and multimodal data. Genom Proteom Bioinform. 2025;23:qzaf072.Google Scholar Download referencesAcknowledgementsThis work is sponsored by General Project of the Educational Department of Liaoning Province (LJKMZ20221255 and LJ212510161042 to S.H.), General Project of the Department of Science and Technology of Liaoning Province (2024-MSLH-111 to SH), National Natural Science Foundation of China (32171290 to HL), Research Platform Construction Project of the Educational Department of Liaoning Province (LJ232510161002 to H.L.), and Interdisciplinary Research Cooperation Project Team Funding of Dalian Medical University [JCHZ2023008 to HL]. We thank Dr Juan Shi at Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences for providing pMSCV-LTR-dCas9-VP64-BFP and pSLQ1651-sgTelomere (F + E) plasmids. We thank Biorender for providing support with the graphical abstract and model diagram.Author informationAuthors and AffiliationsInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, PR ChinaChutong Lai, Wen Fu, Jiaxin Liu, Shuai Hou & Haixin LeiLiaoning Provincial Key Laboratory of Nucleic Acids Biology, Dalian Medical University, Dalian, PR ChinaChutong Lai, Wen Fu, Jiaxin Liu, Shuai Hou & Haixin LeiDepartment of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Trans-plantation, The Second Hospital of Dalian Medical University, Dalian, PR ChinaJinsong YanCollege of Basic Medical Sciences, Hainan Medical University, Haikou, PR ChinaHaixin LeiAuthorsChutong LaiView author publicationsSearch author on:PubMed Google ScholarWen FuView author publicationsSearch author on:PubMed Google ScholarJiaxin LiuView author publicationsSearch author on:PubMed Google ScholarShuai HouView author publicationsSearch author on:PubMed Google ScholarJinsong YanView author publicationsSearch author on:PubMed Google ScholarHaixin LeiView author publicationsSearch author on:PubMed Google ScholarContributionsChutong Lai: Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft. Wen Fu: Formal analysis, Resources. Jiaxin Liu: Data curation, Formal analysis, Resources. Shuai Hou: Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing – review & editing. Jinsong Yan: Funding acquisition, Project administration, Writing – review & editing. Haixin Lei: Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing – review & editing.Corresponding authorsCorrespondence to Shuai Hou, Jinsong Yan or Haixin Lei.Ethics declarationsCompeting interestsThe authors declare no competing interestsEthicsThe animal experimental protocol of this study was reviewed and approved by the Animal Ethics Committee of Dalian Medical University (Approval No.: AEE22115). The experiment was conducted in strict compliance with animal ethics standards to minimize animal suffering and ensure the scientific validity of the study.Additional informationPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Edited by Dr Francesca BernassolaSupplementary informationclean version of Supplementary Figure legends (download DOCX )Supplemental-Figure 1 (download TIF )Supplemental-Figure 2 (download TIF )Supplemental-Figure 3 (download TIF )Supplemental-Figure 4 (download TIF )Supplemental-Figure 5 (download TIF )Supplemental-Figure 6 (download TIF )Table S1 (download XLSX )Table S2 (download XLSX )Table S3 (download XLSX )Table S4 (download XLSX )Table S5 (download XLSX )Table S6 (download XLSX )Table S7 (download XLSX )Original Data (download PDF )Rights and permissionsOpen Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Reprints and permissionsAbout this articleDownload PDF